Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

SNTA

Synta Pharmaceuticals Corp. (MM) (SNTA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNTA
DataOraFonteTitoloSimboloCompagnia
29/07/201621:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201623:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
26/07/201621:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201623:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
22/07/201617:30GlobeNewswire Inc.Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading Cardiovascular-Metabolic Diseases and NASH CompanyNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
21/07/201622:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
20/07/201622:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
06/07/201622:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
01/07/201613:35PR Newswire (US)Why Investors Have These Biotech Stocks on Their Radar? - Synta Pharma, Idera Pharma, Threshold Pharma, and Viking Therapeuti...NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201622:15Business WireSynta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal PharmaceuticalsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/06/201622:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/06/201613:00Business WireSynta Pharmaceuticals to Present at Upcoming Investor Conferences in JuneNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
27/05/201614:20PR Newswire (US)Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat BiologicsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
19/05/201612:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
29/04/201614:33Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
28/04/201612:12Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
14/04/201613:00Business WireSynta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH CompanyNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
13/11/201517:22Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
05/11/201523:20Business WireSynta Reports Third Quarter 2015 Financial ResultsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
21/10/201501:30Business WireSynta Announces Termination for Futility of Ganetespib Phase 3 GALAXY-2 Trial in Lung CancerNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/10/201513:30Business WireSynta Pharmaceuticals Announces Formation of Expert Oncology PanelNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
09/09/201514:00Business WireSynta Names Alan C. Rigby, Ph.D. Chief Scientific OfficerNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
08/09/201514:00Business WireSynta Announces Presentations at the 16th Annual World Conference on Lung CancerNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/09/201522:01Business WireSynta to Participate in FBR Second Annual Healthcare ConferenceNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
06/08/201518:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
06/08/201513:00Business WireSynta Reports Second Quarter 2015 Financial ResultsNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
30/07/201522:01Business WireSynta to Host Conference Call and Webcast of Second Quarter 2015 Financial Results on August 6, 2015NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
23/06/201514:00Business WireSynta Announces Journal Publication Describing Complementary Activity of Hsp90 Inhibition & Immune Checkpoint Blockade for Ca...NASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
16/06/201522:01Business WireSynta to Participate in Upcoming Investor ConferencesNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
02/06/201515:00Business WireSynta Announces Ganetespib Program UpdatesNASDAQ:SNTASynta Pharmaceuticals Corp. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNTA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network